Antonio Valérie, Janvier Brigitte, Brouillet Arthur, Andreani Marise, Raymondjean Michel
UMR (Unité Mixte de Recherche 7079) Physiologie et Physiopathologie, Université Pierre et Marie Curie, Case courrier 256, Bâtiment A, 5èmeétage, 7 quai St Bernard, 75252 Paris cedex 05, France.
Biochem J. 2003 Dec 1;376(Pt 2):351-60. doi: 10.1042/BJ20030098.
The inflammation that occurs during rheumatoid arthritis or atherosclerosis is characterized by the release of large amounts of sPLA(2) (group IIA secretory phospholipase A(2)). We have shown previously that the sPLA(2) promoter in SMC (smooth-muscle cells) is activated by interleukin-1beta and cAMP-signalling pathways, through the interplay of multiple transcription factors [Antonio, Brouillet, Janvier, Monne, Bereziat, Andreani, and Raymondjean (2002) Biochem. J. 368, 415-424]. In the present study, we have investigated the regulation of sPLA(2) gene expression in rat aortic SMCs by oxysterols. We found that oxysterol ligands that bind to the LXR (liver X receptor), including 25-HC (25-hydroxycholesterol) and 22( R )-HC, cause the accumulation of sPLA(2) mRNA and an increased enzyme activity. Transient transfection experiments demonstrated that the sPLA(2) promoter is synergistically activated by 22( R )-HC in combination with 9- cis -retinoic acid, a ligand for the LXR heterodimeric partner RXR (retinoid X receptor). Promoter activity was also increased in a sterol-responsive fashion when cells were co-transfected with LXRalpha/RXRalpha or LXRbeta/RXRalpha. Mutagenesis studies and gel mobility-shift assays revealed that LXR/RXR heterodimers regulate sPLA(2) transcription directly, by interacting with a degenerated LXRE (LXR response element) at position [-421/-406] of the sPLA(2) promoter. Chromatin immunoprecipitation revealed the in vivo occupancy of LXR on the sPLA(2) promoter. In addition, the orphan nuclear receptor LRH-1 (liver receptor homologue-1) potentiated the sterol-dependent regulation of the sPLA(2) promoter by binding to an identified promoter element (TCAAGGCTG). Finally, we have demonstrated that oxysterols act independent of interleukin-1beta and cAMP pathways to activate the sPLA(2) promoter. In the present study, we have identified a new pathway activating sPLA(2) gene expression in SMCs.
类风湿性关节炎或动脉粥样硬化期间发生的炎症的特征是大量分泌型磷脂酶A2(sPLA(2),IIA组)的释放。我们之前已经表明,平滑肌细胞(SMC)中的sPLA(2)启动子通过多种转录因子的相互作用被白细胞介素-1β和cAMP信号通路激活[安东尼奥、布鲁耶、扬维耶、莫内、贝雷齐亚、安德烈亚尼和雷蒙德让(2002年)《生物化学杂志》368卷,415 - 424页]。在本研究中,我们研究了氧化甾醇对大鼠主动脉平滑肌细胞中sPLA(2)基因表达的调控。我们发现,与肝脏X受体(LXR)结合的氧化甾醇配体,包括25 - 羟基胆固醇(25 - HC)和22(R)-羟基胆固醇(22(R)-HC),会导致sPLA(2) mRNA的积累和酶活性增加。瞬时转染实验表明,22(R)-HC与9 - 顺式视黄酸(LXR异二聚体伴侣视黄酸X受体(RXR)的一种配体)联合使用可协同激活sPLA(2)启动子。当细胞与LXRα/RXRα或LXRβ/RXRα共转染时,启动子活性也以甾醇应答的方式增加。诱变研究和凝胶迁移率变动分析表明,LXR/RXR异二聚体通过与sPLA(2)启动子[-421/-406]位置的一个简并LXR反应元件(LXRE)相互作用直接调节sPLA(2)转录。染色质免疫沉淀揭示了LXR在体内对sPLA(2)启动子的占据。此外,孤儿核受体肝脏受体同源物1(LRH - 1)通过与一个已确定的启动子元件(TCAAGGCTG)结合,增强了sPLA(2)启动子的甾醇依赖性调控。最后,我们证明氧化甾醇独立于白细胞介素-1β和cAMP信号通路发挥作用来激活sPLA(2)启动子。在本研究中,我们确定了一条在平滑肌细胞中激活sPLA(2)基因表达的新途径。